Tolochenaz, Switzerland

Marlen Knobloch

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • Zurich, CH (2011)
  • Zürich, CH (2014)
  • Tolochenaz, CH (2017 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Achievements of Marlen Knobloch

Introduction

Marlen Knobloch, a prominent inventor based in Tolochenaz, Switzerland, has made significant contributions to the field of biomedical research. With a total of six patents to her name, her work has focused on the development of novel binding molecules aimed at addressing neurological disorders, particularly Alzheimer's disease. Through her innovative approaches, she has aimed to improve treatment options and enhance patient outcomes.

Latest Patents

Marlen Knobloch's latest patents provide groundbreaking methods for creating disease-specific binding molecules. One notable patent describes a method of providing these molecules that recognize neoepitopes of disease-associated proteins prevalent in patients suffering from neurological disorders. These specific binding molecules include human antibodies, their fragments, derivatives, and variants. Additionally, the patents detail pharmaceutical compositions containing these binding molecules, as well as methods for screening new binding molecules, which may serve as targets in treating conditions like Alzheimer's disease.

Career Highlights

Marlen has had an illustrious career, having worked at prestigious institutions such as the University of Zurich and the University of Zürich. Her academic and research endeavors have positioned her as an influential figure in the field of innovation, particularly in therapeutic developments for neurodegenerative diseases.

Collaborations

Throughout her career, Marlen Knobloch has collaborated with esteemed colleagues, including notable researchers such as Roger Nitsch and Jan Grimm. These partnerships have facilitated the advancement of her research and the practical application of her innovative concepts.

Conclusion

Marlen Knobloch continues to push the boundaries of science and innovation in the healthcare space, specifically addressing the urgent need for effective treatments for neurological disorders. With her groundbreaking patents and steadfast dedication to research, she remains a significant contributor to the advancement of biomedical innovations that have the potential to change many lives for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…